Skip to main content
Atrás
Watch Compare

Imunon, Inc.

Calidad de datos: 83%
IMNN
Nasdaq Manufacturing Chemicals
$2.92
▼ $0.14 (-4.58%)
Cap. Mercado: 11.95 M
Precio
$3.05
Cap. Mercado
11.95 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -14.18 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-430.02%
Below sector avg (-53.53%)
ROIC-280.21%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio1.73
Interest CoverageN/A

Valoración

PE (TTM)
-0.82
Above sector avg (-1.48)
P/B Ratio2.93
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1366 pares)
Métrica Acción Mediana del Sector
P/E -0.8 -1.5
P/B 2.9 1.6
ROE % -430.0 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

4 analistas
Buy
Actual
$2.92
+636.3%
Objetivo
$21.50
$12.00
$20.50
$33.00
Pronóstico
P/E Futuro -0.93
EPS Futuro -$3.14
Ingresos Est. 0.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$3.14
-$5.55 – -$1.75
 0.0 3
FY2026 -$3.11
-$4.14 – -$2.45
 0.0 3

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$1.82 -$1.30 +28.6%
Q32025 -$1.82 -$1.16 +36.4%
Q22025 -$4.34 -$1.87 +56.9%
Q12025 -$4.66 -$3.65 +21.7%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -14.50 M
ROE -430.02% ROA -163.08%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -14.18 M
ROIC -280.21% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.73
Interest Coverage N/A Asset Turnover N/A
Working Capital 3.06 M Tangible Book Value 4.08 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.82 Forward P/E N/A
P/B Ratio 2.93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -118.59%
Market Cap 11.95 M Enterprise Value 6.70 M
Per Share
EPS (Diluted TTM) -6.83 Revenue / Share N/A
FCF / Share -3.61 OCF / Share -3.54
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 97.81%
SBC-Adj. FCF -14.53 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 500,000.0 500,000.0 500,000.0
Net Income -14.50 M -18.62 M -19.51 M -35.90 M -20.77 M
EPS (Diluted) -6.83 -1.62 -2.16 — —
Gross Profit — — — — —
Operating Income -14.65 M -19.13 M -21.03 M -24.92 M -21.01 M
EBITDA — — — — —
R&D Expenses 7.78 M 11.64 M 11.29 M 11.73 M 10.62 M
SG&A Expenses — — — — —
D&A — 240,000.0 248,000.0 731,629.0 702,918.0
Interest Expense — 197,080.0 197,080.0 5.03 M 569,881.0
Income Tax — -1.28 M -1.28 M -1.57 M -1.38 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12.29 M 9.72 M 21.92 M 43.98 M 74.05 M
Total Liabilities 5.23 M 5.47 M 8.53 M 14.65 M 18.25 M
Shareholders' Equity 7.06 M 4.24 M 13.39 M 29.33 M 55.80 M
Total Debt — — — 5.96 M 5.85 M
Cash & Equivalents 8.78 M 5.87 M 5.84 M 11.49 M 19.59 M
Current Assets 10.72 M 8.01 M 18.24 M 37.15 M 51.95 M
Current Liabilities 4.62 M 4.79 M 7.39 M 10.04 M 6.77 M